Small Pharmaceuticals
Market Cap
₹14,498 ₹14,498 Cr.
P/E
87.03
PEG
6.45
PEG = P/E ÷ 5yr Forward EPS CAGR
5yr Forward EPS CAGR Thesis - Base Case

- The thesis comes live if test-kit volume scales within existing capacity and assay commercialization supports demand without material tender or customer delays.- The bull path combines faster kit-volume growth with stronger realization; the bear path reflects volume shortfall, weaker pricing, delayed commercialization and underused capacity.

Key Ratios

Debt to Equity
Debt to Equity
0.35
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
5.60 %
Institutions
Institutions
17.88 %
Market cap
Market cap
14,498 Cr
No. of Shareholders
No. of Shareholders
2.34 L
OPM (%)
OPM (%)
-
PE
PE
87.03
Prom Holding
Prom Holding
41.29 %
ROCE (%)
ROCE (%)
17.36
ROE (%)
ROE (%)
14.25
Sales
Sales
1,445 Cr
  • Molbio Diagnostics
  • Poly Medicure
  • Dr. Lal Pathlabs
Last updated on
      Price Range

      See where the stock is trading versus its 52-week high and low.

      Low
      926
      52W Range
      High
      1294
      Timeline

      Key company specific updates.

      Custom financial statement

      Edit rows

      Forensics

      6 Yes

      Positive for this company

      4 Neutral

      Neutral for this company

      3 No

      Negative for this company

      4 No Data

      Insufficient data to analyse

      Revenue mix

      Product Wise Break-Up

      Location Wise Break-Up

      Asset Break-Up - Geography Wise

      Peer Comparison

      FAQs on Molbio Diagnostics Ltd. Business

      Molbio Diagnostics Limited, incorporated in 2000, is engaged in developing, manufacturing and commercializing point-of-care molecular diagnostic solutions. The company operates in the healthcare diagnostics segment, offering rapid testing solutions for infectious and non-communicable diseases through its Truenat platform.

      Molbio Diagnostics major competitors are Poly Medicure, Dr. Lal Pathlabs, Metropolis Health., Vijaya Diagnostic.
      Market Cap of Molbio Diagnostics is ₹12,907 Crs.
      While the median market cap of its peers are ₹16,511 Crs.

      Molbio Diagnostics seems to be less financially stable compared to its competitors.
      Altman Z score of Molbio Diagnostics is 9.93 and is ranked 4 out of its 5 competitors.

      Company Filing

      2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
      Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
      Earnings Release
      Investor Presentation Sep
      Conference Call
      Conference Call SummaryCon Call Summary

      Discussions & Analysis

      []
      Ideas Dashboard
      Results
      Timeline
      Watchlist
      Portfolio
      Alerts
      Stock Screener
      Market
      Raw Material